can i switch from tirzepatide to retatrutide vs Semaglutide and Tirzepatide: GLP-3 Facts explained Switching between tirzepatide and retatrutide

Reconstituted MT-2 must be stored at 28C and used within 30 days

Methionine restriction restores a younger metabolic phenotype in adult mice with alterations in fibroblast growth factor 21

FDA-APPROVED INDICATIONS Type 2 diabetes As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus Limitations of use: has not been studied in patients with a history of pancreatitis TYPE 2 DIABETES RCT SURPASS-2 trial - Tirzepatide vs Semaglutide in Patients with Type 2 Diabetes, NEJM (2021) [PubMed abstract] The SURPASS-2 trial enrolled 1879 adults with type 2 diabetes who were inadequately controlled with metformin at a dose of at least 1500 mg per day Main inclusion criteria Age 18 years T2DM uncontrolled with metformin at 1500 mg/day A1C of 7 - 10.5% BMI 25 and stable for 3 months Main exclusion criteria Type 1 diabetes GFR 50 ng/L

However, body composition data compared to other GLP-1 RAs remain limited

"Base volume is king, and you can't shortcut it," added Impey